Ratnakar Securities Pvt. Ltd.

GLENMARK LIFE SCIENCES LTD.

NSE : GLSBSE : 543322ISIN CODE : INE03Q201024Industry : Pharmaceuticals & DrugsHouse : Glenmark

BSE1308.8016.95 (+1.31 %)

PREV CLOSE ( ) 1291.85

OPEN PRICE ( ) 1291.85

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 7763

TODAY'S LOW / HIGH ( )1257.70 1335.00

52 WK LOW / HIGH ( )608.55 1335

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 23-06 2011

Management Info

Hiren K Patel - Chairman Yasir Rawjee - Managing Director

Registered Office

Address Plot No. 170-172,Chandramouli Industrial Estate,Mohol Bazarpeth,
Solapur,
Maharashtra-413213

Phone 02189 234456/234246

Email complianceofficer@glenmarklifesciences.com

Website www.glenmarklifesciences.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

05Aug Glenmark Life Sciences leads the gaine
Glenmark Life Sciences is currently trading at Rs. 942.00, up by 62.20 p..

26Jul Glenmark Life Sciences reports 18% fal
Glenmark Life Sciences has reported results for first quarter ended June..

16Jul Glenmark Life Sciences informs about d
Glenmark Life Sciences has informed that the exchange has received Discl..

10Jul Notice of Offer for Sale of Shares by
Glenmark Pharmaceuticals Limited and Mr. Glenn Mario Saldanha (the "Sell..

22Jun Glenmark Life Sciences informs about a
Glenmark Life Sciences has informed that the Officials of the Company wi..

Financials

in Millions

	QTR Jun 24	ANNUAL 24
Net Profit	1114.83	4708.88
Gross Profit	1502.38	6312.9
Operating Profit	1649.78	6862.88
Net Sales	5886.16	22832.14

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE) 12806.30 (2.56%)	M.Cap ( in Cr)16430.34
Sanofi India (BSE) 7212.90 (0.85%)	M.Cap ( in Cr)16611.76
Samrat Pharmachem (BSE) 632.30 (9.61%)	M.Cap ( in Cr)195.36
Strides Pharma Scien (BSE) 1392.10 (2.85%)	M.Cap ( in Cr)12801.50
Hester Biosciences (BSE) 2437.40 (1.49%)	M.Cap ( in Cr)2073.46

Shareholding Pattern

	PROMOTERS	82.85%
	NON-INSTITUTION	10.76%
	MUTUAL FUNDS/UTI	1.01%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Old Bridge Focused ...	3.13
Union Innovation & ...	1.47
Union Value Fund-Reg(G)	1.41
Union Small Cap Fun...	1.34
Navi Aggressive Hyb...	1.25
Union Multicap Fund...	1.21

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

GLENMARK LIFE SCIENCES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES